Accounting: EisnerAmper

CD Diagnostics has retained the accounting firm EisnerAmper to handle taxes, accounting and financial issues. EisnerAmper offers responsive accounting, consulting and tax services with an entrepreneurial focus, providing clients with smart, analytical insights delivered in an approachable style.

General Counsel: Kathleen M. Shay, Duane Morris, LLP

Kathleen Shay is a member of the Business Law section of the American Bar Association and the Corporation, Banking and Business Law section of the Pennsylvania Bar Association. She is former chair of the Executive Committee of the Business Law Section of the Philadelphia Bar Association and serves on the board of directors of the Philadelphia Chapter of the Association for Corporate Growth. She has extensive experience in representing companies of various sizes in stock financing, restructuring, venture capital financing and issuance of convertible notes and warrants. Ms. Shay has served on multiple boards including: MAC Alliance, Women Inventing Next, PA Biotechnology Association and the Technology Council of Eastern Pennsylvania as well as Villanova University, Academy of Notre Dame de Namur and the Delaware Valley Venture Group. She has published multiple papers on Biotechnology law and lectures numerous times annually on various life sciences issues. In 2010, she was awarded the prestigious .Consultant of the Year. award by the Philadelphia Business Journal.

Intellectual Property Counsel: Kathryn Doyle, Ph.D., Saul Ewing, LLP

Dr. Doyle has practiced Intellectual Property law since 1991. She has a BS in Microbiology, a Masters in Virology and a Ph.D., in Virology and Cell and Molecular Biology. She has experience in all aspects of life sciences patent law, including biotechnology, pharmaceuticals and genomics. She is experienced in patent procurement, due diligence, infringement and invalidity opinions as well as patent portfolio management and patent litigation. Prior to practicing law, Kathryn conducted research in herpes virology and taught virology and molecular biology to graduate, undergraduate and medical students. She was an adjunct professor at Temple Law School, teaching biotechnology law for many years. Kathryn is registered to practice before the U.S. Patent and Trademark Office.

Regulatory Counsel: Jeffrey Gibbs, Hyman, Phelps, & McNamara

Mr. Gibbs has represented health care companies on FDA-related matters since 1984. He advises companies on a wide variety of issues, including product approvals, marketing, clinical studies, and enforcement. Previously, he served in the Chief Counsel's Office of the U.S. Food and Drug Administration, where he became an Associate Chief Counsel for Enforcement. While at the FDA, Mr. Gibbs received the FDA Award of Merit. He also was appointed a Special Assistant United States Attorney for the District of Columbia. Mr. Gibbs has written and lectured extensively on a variety of FDA-related topics. Mr. Gibbs served as a member of the Editorial Advisory Board for the Food and Drug Law Journal from 1998 to 2004, and was Chair in 2003-2004. He is currently on the editorial advisory board of IVD Technology and Guide to Good Clinical Practices, and is a member of the Human Subjects Research Board for George Mason University. He is a graduate of Princeton University (1975 summa cum laude) and the New York University School of Law (1978 with honors).